Similar articles for PMID: 18344441

Year	Number of Results
1962	1
1965	1
1995	4
1997	1
1999	1
2000	1
2001	3
2004	3
2005	2
2006	5
2007	10
2008	10
2009	4
2010	2
2011	2
2012	5
2013	4
2014	9
2015	5
2016	4
2017	3
2018	3
2019	2
2020	3
2021	4
2022	2
2023	1
2024	0

1

6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications.

Jager PL, Chirakal R, Marriott CJ, Brouwers AH, Koopmans KP, Gulenchyn KY. Jager PL, et al. J Nucl Med. 2008 Apr;49(4):573-86. doi: 10.2967/jnumed.107.045708. Epub 2008 Mar 14. J Nucl Med. 2008. PMID: 18344441 Free article. Review.

2

18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors.

Minn H, Kemppainen J, Kauhanen S, Forsback S, Seppänen M. Minn H, et al. PET Clin. 2014 Jan;9(1):27-36. doi: 10.1016/j.cpet.2013.08.013. Epub 2013 Oct 2. PET Clin. 2014. PMID: 25029931 Review.

3

Role of (18) F-FDOPA PET/CT imaging in endocrinology.

Santhanam P, Taïeb D. Santhanam P, et al. Clin Endocrinol (Oxf). 2014 Dec;81(6):789-98. doi: 10.1111/cen.12566. Epub 2014 Sep 1. Clin Endocrinol (Oxf). 2014. PMID: 25056984 Review.

4

PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes.

Shamim SA, Kumar A, Kumar R. Shamim SA, et al. PET Clin. 2015 Jul;10(3):411-21. doi: 10.1016/j.cpet.2015.03.005. Epub 2015 Apr 14. PET Clin. 2015. PMID: 26099675 Review.

5

Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.

Kauhanen S, Seppänen M, Minn H, Gullichsen R, Salonen A, Alanen K, Parkkola R, Solin O, Bergman J, Sane T, Salmi J, Välimäki M, Nuutila P. Kauhanen S, et al. J Clin Endocrinol Metab. 2007 Apr;92(4):1237-44. doi: 10.1210/jc.2006-1479. Epub 2007 Jan 16. J Clin Endocrinol Metab. 2007. PMID: 17227804

6

Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.

Koopmans KP, Neels OC, Kema IP, Elsinga PH, Sluiter WJ, Vanghillewe K, Brouwers AH, Jager PL, de Vries EG. Koopmans KP, et al. J Clin Oncol. 2008 Mar 20;26(9):1489-95. doi: 10.1200/JCO.2007.15.1126. J Clin Oncol. 2008. PMID: 18349401

7

The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma.

Timmers HJ, Hadi M, Carrasquillo JA, Chen CC, Martiniova L, Whatley M, Ling A, Eisenhofer G, Adams KT, Pacak K. Timmers HJ, et al. J Nucl Med. 2007 Oct;48(10):1599-606. doi: 10.2967/jnumed.107.042721. Epub 2007 Sep 14. J Nucl Med. 2007. PMID: 17873132 Free article. Clinical Trial.

8

Terminal ileum neuroendocrine incidentaloma in a patient with sporadic medullary thyroid carcinoma: findings from 18F-FDOPA PET/CT investigation.

Imperiale A, Rust E, Boulanger C, Roedlich MN, Ollier JC, Schneegans O. Imperiale A, et al. Clin Nucl Med. 2012 Aug;37(8):e206-8. doi: 10.1097/RLU.0b013e31824c5e04. Clin Nucl Med. 2012. PMID: 22785529

9

Role of 18F-fluorodeoxyglucose PET in the study of neuroendocrine tumors.

Panagiotidis E, Bomanji J. Panagiotidis E, et al. PET Clin. 2014 Jan;9(1):43-55. doi: 10.1016/j.cpet.2013.08.008. Epub 2013 Oct 4. PET Clin. 2014. PMID: 25029933 Review.

10

Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia.

Tessonnier L, Sebag F, Ghander C, De Micco C, Reynaud R, Palazzo FF, Conte-Devolx B, Henry JF, Mundler O, Taïeb D. Tessonnier L, et al. J Clin Endocrinol Metab. 2010 Jan;95(1):303-7. doi: 10.1210/jc.2009-1357. Epub 2009 Nov 13. J Clin Endocrinol Metab. 2010. PMID: 19915018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

86 results

Results by year